This PowerPoint based report gives an important expert analysis on how COVID-19 will affect Inovio Pharmaceuticals Inc. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.
- The coronavirus (COVID-19) company impact report analyses how the pandemic will impact Inovio Pharmaceuticals Inc. performance. Inovio’s focus is on DNA-based vaccines requiring a novel route of administration
- Inovio’s pipeline is most active in early-stage drug development
- INO-4800 is Inovio’s COVID-19 vaccine
- Funding from different sources for INO-4800
Reasons To Buy
- An overview of how Inovio Pharmaceuticals Inc. will be affected by the COVID-19 pandemic.